Skip to main content
Veterinary Medicines

NOBIVAC KC

Authorised
  • Bordetella bronchiseptica, strain B-C2, Live
  • Canine parainfluenza virus, strain Cornell, Live

Product identification

Medicine name:
НОБИВАК KC
NOBIVAC KC
Active substance:
  • Bordetella bronchiseptica, strain B-C2, Live
  • Canine parainfluenza virus, strain Cornell, Live
Target species:
  • Dog
Route of administration:
  • Nasal use

Product details

Active substance and strength:
  • Bordetella bronchiseptica, strain B-C2, Live
    9.70
    log10 colony forming unit(s)
    /
    0.40
    millilitre(s)
  • Canine parainfluenza virus, strain Cornell, Live
    5.80
    log10 50% tissue culture infectious dose
    /
    0.40
    millilitre(s)
Pharmaceutical form:
  • Nasal drops, lyophilisate and solvent for suspension
Withdrawal period by route of administration:
  • Nasal use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AF
Authorisation status:
  • Valid
Authorised in:
  • Bulgaria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Bulgarian Food Safety Authority
Authorisation number:
  • 0022-1504
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 13/10/2024

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 13/10/2024

Labelling

This document does not exist in this language (English). You can find it in another language below.
Bulgarian (PDF)
Published on: 13/10/2024
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."